We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





MEDLAB Europe 2018 Presents Latest Technologies and Developments

By LabMedica International staff writers
Posted on 04 Oct 2018
MEDLAB Europe 2018, which took place in Barcelona, Spain, from October 2-4, 2018, featured over 150 exhibitors showcasing the latest cutting-edge technologies and recent developments in the medical laboratory industry. More...
The second edition of the show welcomed more than 2,600 international visitors and delegates, offering international manufacturers a chance to network with over 1,000 medical dealers and distributors from Spain, Italy, France, Germany, Portugal and other countries.

Alongside the exhibition, the show hosted multi-disciplinary CME-accredited conferences over three days that covered a range of topics, including Point of Care Testing (POCT), immunology, laboratory management anatomic pathology, clinical microbiology and hematology. The conferences tackled current challenges and developments key to the European laboratory and diagnostics market. These areas included the latest in clinical diagnostics development to review the expanding role of laboratory medicine and discuss the key aspects in improving overall patience care and delivery, from new methods of effective lab management to the development of techniques in detecting diseases. This provided an opportunity to learn about advances in science and their applications in laboratory medicine that will improve practice through improving patient outcomes.

The show also hosted free-to-attend workshops in Spanish designed specifically for laboratory technicians, covering topics such as automation, next-generation sequencing and mass spectrometry.



New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Prefilled Tubes
Prefilled 5.0ml Tubes
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.